- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/30 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 263/30
Total number of patents in this class: 73
10-year publication summary
|
4
|
4
|
6
|
5
|
2
|
5
|
1
|
2
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
7 |
| Cumberland Pharmaceuticals Inc. | 101 |
6 |
| Vanderbilt University | 1901 |
6 |
| Toray Industries, Inc. | 6936 |
5 |
| Merck Sharp & Dohme Corp. | 2194 |
3 |
| Boehringer Ingelheim International GmbH | 4650 |
3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 702 |
3 |
| Dompé Farmaceutici S.p.A. | 269 |
3 |
| Allergan, Inc. | 2349 |
2 |
| ChemoCentryx, Inc. | 385 |
2 |
| Corteva Agriscience LLC | 2669 |
2 |
| Merck Sharp & Dohme LLC | 3748 |
2 |
| Amgen Inc. | 4074 |
1 |
| FUJIFILM Corporation | 29367 |
1 |
| The General Hospital Corporation | 4733 |
1 |
| The Trustees of Columbia University in the City of New York | 3568 |
1 |
| Mayo Foundation for Medical Education and Research | 3206 |
1 |
| Augusta University Research Institute, Inc. | 145 |
1 |
| Avexxin AS | 46 |
1 |
| Beijing Molecule Science and Technology Co., Ltd. | 12 |
1 |
| Other owners | 21 |